2014 Orlando, FL
Total Page:16
File Type:pdf, Size:1020Kb
Engineering and Urology Society 29th Annual Meeting Saturday May 17th, 2014 Orlando, FL http://engineering-urology.org/ The Engineering and Urology Society offers a unique opportunity for collaboration where engineering innovation meets clinical demand. This leads to an unparalleled exchange of ideas and routes to address clinical problems with engineering solutions. The ultimate forum where these interchanges occur is at the Annual Meeting of the Engineering and Urology Society held in conjunction with the Annual American Urological Association Meeting. The EUS meeting is also the only dedicated section of the Endourology Society at the AUA. The Annual Meeting of the Engineering and Urology Society offers the delegates an opportunity to present and learn about the latest research developments in urologic technology. The morning session consists of state of the art lectures and discussions in cutting-edge areas of technology. The afternoon poster sessions and ever-growing subgroup meetings allow members to present their work, discuss, and obtain further feedback and ideas from fellow technophiles. This year’s 29th Annual Meeting will take place on May 17th, and has been organized by program chairmen Stavros Gravas, Bodo Knudsen, and M. Pilar Laguna. The morning sessions will begin with a thought- provoking discussion on the intersection of lab training and new imaging technology and urology. Following that, the spotlight is turned to advances in evidence making in uro-technology. Next, colleagues from the European Association of Urology (EAU), Uro-Technology section (ESUT) will present developments for new endoscopic instrumentation. After the lunch break, a brand-new session on “Innovations in Urology” will be held at the Science & Technology Hall, highlighting the grant and patent application processes which are an integral part of engineering and urology. Current updates on LESS and NOTES returns this year. The Stent Working Group will discuss about new designs with challenging case scenarios. The final session will review image-guided interventions, focusing on the management of diagnosis and treatment of renal masses and upper tract urothelial carcinoma. Two poster session during the afternoon will provide a forum for uro-technology researchers to present and discuss their latest findings. The review of the abstracts for the poster sessions was performed online by a group of 87 reviewers from around the world. Each paper received between 30 and 35 reviews. We would like to thank the reviewers, listed at the end of this program book, for their essential contribution to the quality of the meeting and their constructive comments that they made for the research. Based on the peers review, two equally ranked abstracts have been selected. Top 10 abstracts have also been selected and are listed at the end of this program book. Their authors are invited to submit full articles to the Journal of Endourology on the respective topics. We gratefully thank all reviewers for their hard work, objective scoring, and contribution to the success of the meeting. The society also presents Best Reviewer Awards based on the grading performance and the number of reviews performed. The Best Reviewer Awards are presented to Drs. Jeffrey Cadeddu, Mohamed Elkoushy, Petrisor Geavlete, Kamol Panumatrassamee, Govindarajan Srimathveeravalli, Chong Xue, and Hessel Wijkstra. We congratulate all award winners and welcome all urologists, engineers, and scientists to join us for this unique multi and interdisciplinary experience. As always, we are grateful to Dr. George Nagamatsu, the founder and first president of the society for setting the foundations based upon which we meet. Please visit the website http://engineering-urology.org for a complete version of this program including the abstracts presented. Thank you for your continued scientific support, Jeffrey Cadeddu Koon Ho Rha Dan Stoianovici 29th EUS Annual Meeting, May 17, 2014, Orlando, FL Page 2 of 82 CONTINUING MEDICAL EDUCATION AUA ACCREDITATION INFORMATION Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Credit Designation: The American Urological Association designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias. AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments. Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest: • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Content Review Committee or its subgroup. • Limit content to evidence with no recommendations • Introduction of a debate format with an unbiased moderator (point-counterpoint) • Inclusion of moderated panel discussion • Publication of a parallel or rebuttal article for an article that is felt to be biased • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations • Divestiture of the relationship by faculty Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses. Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA. Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association. Special Assistance/Dietary Needs: The American Urological Association complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk. 29th EUS Annual Meeting, May 17, 2014, Orlando, FL Page 3 of 82 CONTINUING MEDICAL EDUCATION FACULTY DISCLOSURES: Best, Sara: American Urological Association: Meeting participant or lecturer Bianchi, Giampaolo: Nothing to disclose Borin, James: Cook Medical: Consultant or Advisor, Journal of Endourology, Videourology Part B: Health publishing, J. Laparoendoscopic & Advanced Surgical Techniques, Part B: Videoscopy: Health publishing Castle, Erik P: Dendreon: Consultant or Advisor Clayman, Ralph V: Applied Urology: Investment interest, Greenwald, Inc: Other, Orthopedic Services, Inc. (OSI): Other, Boston Scientific: Other, Cook Urological: Other Cookson, Michael: Nothing to disclose Cristancho, Sayra: Nothing to disclose Dahm, Philipp: Medtronics: Consultant or Advisor De Bruin, Daniel Martin: Nothing to disclose Derweesh, Ithaar: GlaxoSmithKline, Inc: Scientific study or trial Gravas, Stavros: GSK: Consultant or Advisor, meeting participant or lecturer, Pierre Fabre Medicament: Consultant or Advisor, meeting participant or lecturer Irwin, Brian: Nothing to disclose Janetschek, Gunter: Storz: Scientific study or trial Jichlinski, Patrice: Nothing to disclose Joshi, Hrishi: Nothing to disclose Knoll, Thomas: Scholly: Consultant or advisor, Richard Wolf: Meeting participant or lecturer, Cook Medical: Scientific study or trial, Boston Scientific: Consultant or advisor, meeting participant or lecturer, Karl Storz: Consultant or Advisor, meeting participant or lecturer Knudsen, Bodo: Boston Scientific: Consultant or Advisor, Cook Urological: Meeting participant or lecturer, Olympus Surgical: Consultant or Advisor Kulkarni, Ravindra: Nothing to disclose Laguna Pes, Pilar M.: Nothing to disclose Landman, Jaime: Cook Urological: Consultant or Advisor, Owner, Product Development, Galil Medical: Consultant